Home Cart 0 Sign in  

[ CAS No. 328-38-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 328-38-1
Chemical Structure| 328-38-1
Structure of 328-38-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 328-38-1 ]

Related Doc. of [ 328-38-1 ]

Alternatived Products of [ 328-38-1 ]

Product Details of [ 328-38-1 ]

CAS No. :328-38-1 MDL No. :MFCD00063088
Formula : C6H13NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :ROHFNLRQFUQHCH-RXMQYKEDSA-N
M.W : 131.17 Pubchem ID :439524
Synonyms :
(R)-Leucine

Calculated chemistry of [ 328-38-1 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.83
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 35.44
TPSA : 63.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.18 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.14
Log Po/w (XLOGP3) : -1.52
Log Po/w (WLOGP) : 0.44
Log Po/w (MLOGP) : -1.82
Log Po/w (SILICOS-IT) : -0.15
Consensus Log Po/w : -0.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.5
Solubility : 417.0 mg/ml ; 3.18 mol/l
Class : Highly soluble
Log S (Ali) : 0.7
Solubility : 652.0 mg/ml ; 4.97 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.14
Solubility : 96.1 mg/ml ; 0.733 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.39

Safety of [ 328-38-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 328-38-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 328-38-1 ]
  • Downstream synthetic route of [ 328-38-1 ]

[ 328-38-1 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 328-38-1 ]
  • [ 28659-87-2 ]
Reference: [1] Patent: US4596675, 1986, A,
[2] Patent: EP1098871, 2003, B1,
[3] Patent: US5594006, 1997, A,
  • 2
  • [ 328-38-1 ]
  • [ 108-24-7 ]
  • [ 19764-30-8 ]
YieldReaction ConditionsOperation in experiment
89%
Stage #1: With sodium hydroxide In water at 5 - 15℃; for 4 - 5 h;
Stage #2: With hydrogenchloride In water at 5 - 15℃; for 2.5 h;
Procedure: The preparation of JV-acetyl-D-Leucine of Compound 10 was carried out by a modified prior art process (/. Am. Chem. Soc, 1951, 73, 3359-3360) as shown in Scheme II below and as described herein.Scheme πA 22 Liter 4-neck vessel was equipped with a thermocouple controller, an overhead mechanic stirrer and two 2.0 Liter addition funnels. The vessel was charged with D.I. H2O (2.45 L) and D-leucine (99percent e.e., 917.Og, 7.0 mol) with agitation. Acetic anhydride (99percent, 2142.0 g, 21.0 mol) and a 20 JV solution of NaOH in H2O (2.45 L, 49.0 mol) were added simultaneously over a 3 to 4 hour period, while the reaction temperature was maintained between 5 to 15 0C. The addition rates of the alkaline solution and acetic anhydride were adjusted along with wet ice cooling to maintain the reaction temperature. The pH of the reaction mixture was maintained slightly alkaline (pH 8-9) and measured every 10 to 15 min with pH indicator strips. The progress of EPO <DP n="36"/>the reaction was determined by HPLC and LC-MS. After the addition was completed, the mixture was agitated for 1 hour and then acidified cautiously with a 37percent HCl solution (4.76 L, 49.0 mol) over a 30-min period. A white solid precipitated and the slurry was stirred for 2 hours at about 5 0C to about 15 0C. The resulting solid was isolated by filtration, washed with D.I. H2O (2.0 L x 7), dried by air-suction for 3 hours and then placed in a vacuum oven under house vacuum at 600C for 16 hours (drying was stopped when the solid lost no more weight). There was obtained 1083 g (89percent) of iV-acetyl-D-leucine (Compound 10) as a white powdery solid with high optical purity (>97percent e.e.). The structure of Compound 10 was confirmed by 1H-NMR and LC-MS analyses, and was used in the next step without further purification
Reference: [1] Patent: WO2006/93719, 2006, A1, . Location in patent: Page/Page column 34; 35
[2] Organic Process Research and Development, 2005, vol. 9, # 5, p. 640 - 645
  • 3
  • [ 328-38-1 ]
  • [ 830-03-5 ]
  • [ 100-02-7 ]
  • [ 19764-30-8 ]
Reference: [1] Canadian Journal of Chemistry, 1991, vol. 69, # 7, p. 1124 - 1130
  • 4
  • [ 328-38-1 ]
  • [ 501-53-1 ]
  • [ 28862-79-5 ]
Reference: [1] Antimicrobial Agents and Chemotherapy, 2017, vol. 61, # 3,
[2] Tetrahedron Asymmetry, 2006, vol. 17, # 17, p. 2469 - 2478
[3] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 14, p. 1871 - 1874
[4] Archiv der Pharmazie, 2018, vol. 351, # 7,
  • 5
  • [ 328-38-1 ]
  • [ 65635-85-0 ]
Reference: [1] Journal of the American Chemical Society, 1987, vol. 109, # 22, p. 6846 - 6848
  • 6
  • [ 67-56-1 ]
  • [ 328-38-1 ]
  • [ 5845-53-4 ]
YieldReaction ConditionsOperation in experiment
92% at 0 - 20℃; for 4.5 h; According to S.G. Davies, H.J. Sanganee, P. Szolcsanyl, Tetrahedron 55 (1999) 3337 as follows: Chosen amino acid (d‑leucine (60.24 mmol)) was suspended in anhydrous MeOH (100 mL) and cooled to 0 °C in an ice/salt bath. Thionyl chloride (SOCl2, 5.1 mL, 70.24 mmol) was added dropwise over 30 min. The cooling bath was removed, the reaction mixture was heated to room temperature and stirred for 4 h. The reaction mixture was then concentrated under reduced pressure. A white product was suspended in dichloromethane (DCM, 3 x 100 mL) and the solvent was distilled out under reduced pressure. This was repeated three times. A white crystalline compound was suspended in ethyl acetate (100 mL), filtered and the solid was washed with ethyl acetate (3 x 20 mL). The white product was dried to constant mass to obtain white powder in 92percent yield for D‑leucine. Characterization of (2R)-1-methoxy-4-methyl-1-oxopentan-2-aminium chloride. White solid; yield 92 percent; mp 149.8-151.5 °C; [αD20] = -12.9° (c 1 H2O). IR (ATR): 2957, 2921, 2842, 2632, 1731, 1588, 1506, 1451, 1248, 1225, 1040  cm‑1. 1H NMR (400 MHz, D2O): δ 4.10 (1H, t, J = 8 Hz, NH‑CH-CHH-CH-(CH3)2), 3.79 (3H, s, O-CH3), 1.85-1.75 (1H, m, NH‑CH-CHH-CH-(CH3)2, 1.75-1.62 (2H, m, NH‑CH-CHH-CH-(CH3)2, NH‑CH‑CH2‑CH‑(CH3)2), 0.96‑0.87 (6H, m, CH3-CH-CH3). 13C NMR (100.79 MHz, D2O): δ 171.5, 53.6, 51.6, 38.9, 24.1, 21.6, 21.1. CNH Analysis: Calc. for C7H15N3O2 (181.66): 1.1.1.1.                        C, 46.28; H, 8.88; N, 7.71. Found: C, 45.99±0.03; H 8.74±0.02; N, 7.69±0.02. HRMS: m/z calc. for C7H15N3O2: 146.11756 [M+H]+; found: 146.11762 [M+H]+.
91% for 18 h; D-Leucine (3.00 g, 22.9 mmol) was added to a solution of acetyl chloride (1.70 mL, 23.9 mmol) in methanol (30 mL). The reaction mixture was allowed to stir for 18 h and then concentrated under reduced pressure. This yielded 3.8 g (91percent) of the title compound. 1H NMR (400 MHz, CD3OD) δ 0.99 (dd, 6H), 1.63-1.87 (m, 3H), 4.10 (dd, IH), 3.81 (s, 3H).
85% at 0 - 22℃; for 26 h; General procedure: To a suspension of 5 g of D-amino acid in 100 mLdry methanol at 0–5°, 8–10 mL thionyl chloridewere added dropwise, the mixture was stirred for 2 hand kept at 20–22° for 24 h. The solvent was evaporatedunder vacuum at 30–40°, the residue wasmixed with dry ether, filtered off, dried, and recrystallizedfrom methanol–ether mixture.
Reference: [1] Angewandte Chemie - International Edition, 2016, vol. 55, # 34, p. 10113 - 10117[2] Angew. Chem., 2016, vol. 128, p. 10267 - 10271,5
[3] Synlett, 2009, # 15, p. 2487 - 2491
[4] Liebigs Annalen der Chemie, 1985, vol. 1985, # 11, p. 2285 - 2300
[5] European Journal of Medicinal Chemistry, 2017, vol. 135, p. 142 - 158
[6] Patent: WO2006/44775, 2006, A2, . Location in patent: Page/Page column 35
[7] Agricultural and Biological Chemistry, 1987, vol. 51, # 2, p. 537 - 548
[8] Tetrahedron Asymmetry, 2000, vol. 11, # 6, p. 1367 - 1374
[9] Russian Journal of Bioorganic Chemistry, 2017, vol. 43, # 4, p. 456 - 462[10] Bioorg. Khim., 2017, vol. 43, # 4, p. 427 - 434,8
[11] Journal of Organic Chemistry, 1986, vol. 51, # 14, p. 2728 - 2735
[12] Phytochemistry (Elsevier), 1988, vol. 27, # 1, p. 77 - 84
[13] Journal of Medicinal Chemistry, 2006, vol. 49, # 24, p. 7215 - 7226
[14] European Journal of Organic Chemistry, 2001, # 12, p. 2329 - 2335
[15] Journal of Organic Chemistry, 2007, vol. 72, # 24, p. 9283 - 9290
[16] Organic Process Research and Development, 2012, vol. 16, # 1, p. 123 - 128
[17] Tetrahedron, 2016, vol. 72, # 51, p. 8486 - 8492
[18] Angewandte Chemie - International Edition, 2018, vol. 57, # 37, p. 11947 - 11951[19] Angew. Chem., 2018, vol. 130, p. 12123 - 12127,5
[20] Patent: CN108610269, 2018, A, . Location in patent: Paragraph 0019-0020
  • 7
  • [ 328-38-1 ]
  • [ 5845-53-4 ]
Reference: [1] Patent: US6048852, 2000, A,
  • 8
  • [ 328-38-1 ]
  • [ 106930-51-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6305 - 6312,8
  • 9
  • [ 161633-97-2 ]
  • [ 328-38-1 ]
  • [ 90989-12-1 ]
Reference: [1] Journal of the American Chemical Society, 1994, vol. 116, # 18, p. 8126 - 8132
Same Skeleton Products
Historical Records

Similar Product of
[ 328-38-1 ]

Chemical Structure| 82152-60-1

A1268045[ 82152-60-1 ]

D-Leucine-1-13C

Reason: Stable Isotope

Chemical Structure| 287484-39-3

A1268184[ 287484-39-3 ]

D-Leucine-15N

Reason: Stable Isotope

Related Functional Groups of
[ 328-38-1 ]

Amino Acid Derivatives

Chemical Structure| 88319-43-1

[ 88319-43-1 ]

(R)-2-Amino-4,4-dimethylpentanoic acid

Similarity: 0.97

Chemical Structure| 102735-53-5

[ 102735-53-5 ]

(S)-2-Amino-3-cyclopropylpropanoic acid

Similarity: 0.97

Chemical Structure| 1509-35-9

[ 1509-35-9 ]

H-D-Allo-Ile-OH

Similarity: 0.97

Chemical Structure| 73-32-5

[ 73-32-5 ]

H-Ile-OH

Similarity: 0.97

Chemical Structure| 27527-05-5

[ 27527-05-5 ]

(S)-2-Amino-3-cyclohexylpropanoic acid

Similarity: 0.97